<DOC>
	<DOC>NCT02323672</DOC>
	<brief_summary>45 individuals were subdivided into 3 groups, 15 patients with oral premalignant lesions, 15 patients with oral malignant lesions and 15 control individuals. Levels of chemerin and MMP-9 were evaluated in serum and saliva of these subjects utilizing the ELISA technique.</brief_summary>
	<brief_title>Salivary and Serum Levels of Chemerin and MMP-9 in Oral Premalignant and Malignant Lesions</brief_title>
	<detailed_description>45 individuals were subdivided into 3 groups, 15 patients suffering from oral premalignant lesions, 15 patients suffering from oral malignant lesions and 15 individuals having age, gender and periodontal status matched with both patients groups acting as a control group. Serum and whole unstimulated saliva samples were collected from all the included groups in order to determine chemerin and MMP-9 in serum and saliva utilizing the ELISA technique.</detailed_description>
	<mesh_term>Mouth Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<criteria>patients with oral premalignant lesions. patients with oral malignant lesions. any systemic disease other than oral premalignant or malignant lesions. smokers. pregnant females. periodontal diseases.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>